• PDF / 169,120 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 88 Downloads / 113 Views

DOWNLOAD

REPORT

---

1 S

Treatment failure: case report In a retrospective single-centre cohort study of 172 patients treated between July 2016 and May 2018, a 66-year-old man* was described, who exhibited treatment with ledipasvir/sofosbuvir, while being treated for chronic hepatitis C genotype 1b infection with decompensated cirrhosis. The man, who had chronic hepatitis C genotype 1b infection with decompensated cirrhosis, received treatment with ledipasvir/sofosbuvir [route and dosage not stated] for 24 weeks. Hepatitis C virus (HCV) RNA was found to be positive following the completion of therapy suggesting relapse and antiviral treatment failure. * Identifying patient details (age, sex and initial) have been obtained through direct communication with the author. Cabalak M, et al. Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection. Tropical Doctor 50: 803502205 141-146, No. 2, Apr 2020. Available from: URL: http://doi.org/10.1177/0049475519892082

0114-9954/20/1822-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 19 Sep 2020 No. 1822